Copyright
©The Author(s) 2025.
World J Methodol. Dec 20, 2025; 15(4): 106591
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.106591
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.106591
Table 1 Baseline characteristics of study participants, n (%)/mean ± SD
Table 2 Histopathology and operation details, n (%)/mean ± SD
Characteristic | Study population n = 10 |
Tumor type: Adenocarcinoma | 8 (80) |
Tumor type: Mixed neuroendocrine non-neuroendocrine neoplasm | 1 (10) |
Tumor type: Mucoepidermoid carcinoma | 1 (10) |
pT11 | 4 (40) |
pT2 | 1 (10) |
pT3 | 5 (50) |
pN01 | 5 (50) |
pN1 | 3 (30) |
pN2 | 2 (20) |
Tumor regression scoring according to Mandard, 2 | 3 (30) |
Tumor regression scoring according to Mandard, 3 | 4 (40) |
Tumor regression scoring according to Mandard, 4 | 1 (10) |
Tumor regression scoring according to Mandard, 5 | 1 (10) |
No neoadjuvant treatment | 1 (10) |
Tumor size in millimeters | 32.7 ± 23.8 |
Palpable tumor, yes | 7 (70) |
Palpable tumor, no | 3 (30) |
Microscopic distance to proximal tumor resection line, mm | 37.3 ± 17.9 |
Macroscopic distance to proximal tumor resection line, mm | 45.3 ± 17.3 |
R0 resection | 10 (100) |
R1 resection | 0 (0) |
Barrett’s dysplasia in resected tissue | 2 (20) |
No Barrett’s dysplasia in resected tissue | 8 (80) |
Table 3 Implantation details, n (%)/mean ± SD
Characteristic | Study population n = 10 |
Distance from incisors to proximal tumor border, cm | 39.3 ± 5.8 |
Distance from surgeon’s proposed proximal resection line to BioXmark®, cm1 | 3.8 (± 1.1) |
Number of implantations per patient | 4 |
Amount of BioXmark® per implantation, μL | 82 ± 17.5 |
BioXmark® visible on intraoperative ultrasound in vivo | 6 (60) |
BioXmark® not visible or missing data on intraoperative ultrasound in vivo | 4 (40) |
BioXmark® visible on intraoperative ultrasound ex vivo | 3 (30) |
BioXmark® not visible or missing data on intraoperative ultrasound ex vivo | 7 (70) |
- Citation: U Solstad T, Mucha AW, Olsen AA, Grossjohann H, Achiam MP. Preoperative marking of the proximal resection margin in esophageal cancer with a surgical fiducial marker: First experiences. World J Methodol 2025; 15(4): 106591
- URL: https://www.wjgnet.com/2222-0682/full/v15/i4/106591.htm
- DOI: https://dx.doi.org/10.5662/wjm.v15.i4.106591